IPP Bureau
Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer
By IPP Bureau - June 08, 2026
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Smile Foundation delivers 20 lakh healthcare treatments in FY26
By IPP Bureau - June 08, 2026
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
Manipal Hospital Dhakuria raises ovarian cancer awareness
By IPP Bureau - June 08, 2026
The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention
Everest Medicines expands Asia-Pacific presence with licensing deal for Bejescin
By IPP Bureau - June 08, 2026
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
Apollo Hospitals holds organ donation awareness
By IPP Bureau - June 08, 2026
Donor families honoured as Apollo highlights over 27,500 transplants performed and calls for greater public participation in organ donation
Kunwar Khurana elevated to Head – Sales and Marketing at Dr. Reddy’s Labs
By IPP Bureau - June 08, 2026
Seasoned pharmaceutical marketing leader brings extensive experience in brand management, sales strategy, and digital engagement to the expanded leadership role
Biocon Academy graduates 156 students at 10th convocation
By IPP Bureau - June 08, 2026
The graduating cohort comprised seven batches across five specialized programs
Yatharth Hospitals appoints Dr. Prahlad Agrawal as CEO & COO
By IPP Bureau - June 08, 2026
Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role
Maiva Pharma sets up advanced sterile injectables manufacturing facility in Tamil Nadu
By IPP Bureau - June 08, 2026
The newly commissioned facility strengthens the ’company’s capabilities in the development and manufacturing of generic and complex sterile injectable products
Awshad launches Calmagummies Gold to tap cannabis-based wellness market
By IPP Bureau - June 08, 2026
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
By IPP Bureau - June 06, 2026
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Alembic Pharma receives USFDA approval for Haloperidol tablets
By IPP Bureau - June 06, 2026
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Dr. L H Hiranandani Hospital expands cancer care with advanced radiation therapy unit
By IPP Bureau - June 06, 2026
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab
By IPP Bureau - June 06, 2026
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Sanofi launches AI-powered agent for sales representatives
By IPP Bureau - June 06, 2026
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
